# Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases

> **NCT00317785** · PHASE2 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 50 (estimated)

## Conditions studied

- Leukemia
- Lymphoma
- Myelodysplastic Syndromes

## Interventions

- **DRUG:** cyclophosphamide
- **DRUG:** cyclosporine
- **DRUG:** methotrexate
- **DRUG:** mycophenolate mofetil
- **DRUG:** sirolimus
- **DRUG:** tacrolimus
- **OTHER:** pharmacological study
- **PROCEDURE:** allogeneic bone marrow transplantation
- **PROCEDURE:** allogeneic hematopoietic stem cell transplantation
- **PROCEDURE:** peripheral blood stem cell transplantation
- **RADIATION:** total-body irradiation

## Key facts

- **NCT ID:** NCT00317785
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2007-11
- **Final completion:** —
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2010-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00317785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00317785, "Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00317785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*